Malignant neoplasms in cyclosporin A-induced autoimmunity (CyA-AI)

作者: K. Will H. Wodzig , Leo J.J. Beijleveld , Jan G.M.C. Damoiseaux , Jan-Willem Arends , Peter J.C. van Breda Vriesman

DOI: 10.1002/(SICI)1097-0215(19970729)72:3<530::AID-IJC24>3.0.CO;2-E

关键词:

摘要: Lethally X-irradiated LEW rats reconstituted with syngeneic bone marrow and given low-dose Cyclosporine A (CyA) for 5 weeks develop, after withdrawal of CyA, symptoms disease resembling graft-vs.-host (GVHD) as seen allogeneic bone-marrow transplantation. Symptoms may include acute dermatitis chronic scleroderma. Since anti-class II MHC cytotoxic lymphocytes are generated in this model, it has been proposed an anti-tumor regimen humans. We now report that treated according to protocol may, cessation CyA administration, paradoxically develop malignant neoplasms. Of 48 experimental animals, 31 developed rapidly progressive subcutaneous and/or intracutaneous tumors commencing at 6 weeks, 13 months CyA. Tumors were mesenchymal origin, usually high-grade sarcoma, adenocarcinoma or both epithelial tumors. Such tumor incidence exceeded the growth controls, subjected thymectomy prior X-irradiation administration. by itself induced no Our results show total body is required development but presence CyA-induced autoimmune increases significantly.

参考文章(36)
J. Wilson, R. Stoll, H. Schön, M. Madörin, P. Donatsch, B. E. Matter, B. Ryffel, G. Rüttimann, Toxicological evaluation of cyclosporin A Archives of Toxicology. ,vol. 53, pp. 107- 141 ,(1983) , 10.1007/BF00302721
H. Shinozuka, H. W. Kunz, A. Hattori, rd T. J. Gill, Thymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine. American Journal of Pathology. ,vol. 128, pp. 111- 120 ,(1987)
Steven I. Hajdu, Pathology of Soft Tissue Tumors ,(1979)
Steven A. Rosenberg, Vincent T. DeVita, Samuel Hellman, Cancer : Principles and Practice of Oncology ,(1982)
M J Kennedy, G B Vogelsang, R A Beveridge, E R Farmer, V Altomonte, A M Huelskamp, N E Davidson, Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. Journal of Clinical Oncology. ,vol. 11, pp. 478- 484 ,(1993) , 10.1200/JCO.1993.11.3.478
M J Kennedy, G B Vogelsang, R J Jones, E R Farmer, A D Hess, V Altomonte, A M Huelskamp, N E Davidson, Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. Journal of Clinical Oncology. ,vol. 12, pp. 249- 257 ,(1994) , 10.1200/JCO.1994.12.2.249
Kevin J. Scanlon, Weizhen Wang, Hong Han, Cyclosporin A suppresses cisplatin-induced oncogene expression in human cancer cells Cancer Treatment Reviews. ,vol. 17, pp. 27- 35 ,(1990) , 10.1016/0305-7372(90)90013-6
G. W. Santos, A. D. Hess, G. B. Vogelsan, Graft-versus-host reactions and disease. Immunological Reviews. ,vol. 88, pp. 169- 192 ,(1985) , 10.1111/J.1600-065X.1985.TB01158.X
GRAHAM E. KELLY, WILLIAM MEIKLE, A. G. ROSS SHEIL, Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Transplantation. ,vol. 44, pp. 429- 434 ,(1987) , 10.1097/00007890-198709000-00021